Office for Disparities Research and Workforce Diversity Webinar Series: Coming Face to Face With Suicide in American Farming

Date and Time September 12, 20232:30–4:00 p.m. ET OverviewThe suicide rate among American farmers is serious and worsening but may not be well explained by either a lack of access to care or demographic characteristics. This webinar will begin with a brief fact book about suicide and American farming that emphasizes the diversity present in farming…

Read More

Initiative Provides Financial Assistance to Idiopathic Hypersomnia Patients

The Assistance Fund, an independent charitable patient assistance organization that helps patients and families facing high medical out-of-pocket costs, launched a new financial assistance program for people living with idiopathic hypersomnia.  The program is designed to help eligible individuals pay for their out-of-pocket medical expenses related to idiopathic hypersomnia, such as copays, health insurance premiums,…

Read More

Child Impulsivity Tied to Sleep Patterns

Getting enough sleep can help children combat the effects of stressful environments and increased levels of impulsivity, according to a study published in Sleep Health from the Youth Development Institute at the University of Georgia. “Stressful environments are shown to make adolescents seek immediate rewards rather than delayed rewards, but there are also adolescents who…

Read More

NLS Eyes Fast-Track Designation for Mazindol ER for Narcolepsy

Swiss clinical-stage biopharmaceutical company NLS Pharmaceutics Ltd issued a letter updating stakeholders on its progress in developing treatments for sleep disorders, which include Mazindol ER for narcolepsy, NLS-4 for idiopathic hypersomnia, and NLS-11 for Kleine-Levin Syndrome. On Aug 25, NLS submitted a fast-track designation application for Mazindol ER to the US Food and Drug Administration…

Read More

Wakix Patent Challenge Rejected by US Patent Office  

The United States Patent and Trademark Office (USPTO) has denied a Petition for Reexamination concerning a patent covering the active ingredient in Harmony Bioscience’s narcolepsy drug Wakix (pitolisant).  The petition was filed in July by Scorpion Capital, which made numerous claims, including that Harmony’s core patent was obtained via fraud and that the patentee misled…

Read More